Ligand validation:8BLJ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 8BLJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BLJ_NAG_A_906	27%	58%	0.204	0.853	0.51	1.1	-	1	0	0	100%	0.9333
8BLJ_NAG_E_903	17%	61%	0.236	0.811	0.46	1.03	-	1	0	0	100%	0.9333
8BLJ_NAG_D_902	16%	60%	0.213	0.78	0.47	1.03	-	1	0	0	100%	0.9333
8BLJ_NAG_F_903	12%	58%	0.299	0.832	0.42	1.19	-	1	0	0	100%	0.9333
8BLJ_NAG_C_905	3%	60%	0.294	0.622	0.41	1.12	-	1	0	0	100%	0.9333
8BLJ_NAG_B_903	2%	44%	0.357	0.617	0.42	1.72	-	3	0	0	100%	0.9333
8BN2_NAG_A_906	78%	18%	0.089	0.931	0.67	2.77	-	5	0	0	100%	0.9333
8BN5_NAG_A_903	73%	19%	0.104	0.932	0.64	2.78	-	5	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.